That's half a million per year. At that price, unless syprine's manufacturing process requires digging diamonds, one could probably save money by hiring a dedicated chemist (100k p/y or thereabout) and giving them the necessary money to make the drug just for one.
If I were an insurance company, I'd consider buying a small pharma outfit and target it at these orphan drugs just to save money.
That's half a million per year. At that price, unless syprine's manufacturing process requires digging diamonds, one could probably save money by hiring a dedicated chemist (100k p/y or thereabout) and giving them the necessary money to make the drug just for one.
If I were an insurance company, I'd consider buying a small pharma outfit and target it at these orphan drugs just to save money.